arXiv:2606. 06196v1 Announce Type: new Abstract: Huntington's disease (HD) is a progressive brain disorder that gradually affects movement, cognitive function, and behavior.
By Lubna M. Abu Zohair, Marta Vallejo, MD Azher Uddin, John R. Woodward, Hind Zantout
arXiv:2604. 07085v2 Announce Type: replace Abstract: In electronic health records (EHRs), clustering patients and distinguishing disease subtypes are key tasks to elucidate pathophysiology and aid clinical decision-making.
By Manar D. Samad, Yina Hou, Shrabani Ghosh
arXiv:2606. 28623v1 Announce Type: new Abstract: Effective sub-typing (also known as grouping or clustering) of patients using their electronic health record (EHR) data can greatly inform precision medicine efforts.
By Md Mozaharul Mottalib, Rahmatollah Beheshti
arXiv:2606. 07135v1 Announce Type: new Abstract: Huntington's disease (HD) is a progressive neurodegenerative disorder that affects motor, cognitive, and behavioral functions, where accurate characterization of disease progression remains essential to improve patient outcome and quality of life.
By Lubna Mahmoud Abu Zohair, Hind Zantout
arXiv:2606. 05488v1 Announce Type: cross Abstract: Identifying subtypes of complex conditions, such as Inflammatory Bowel Disease (IBD), often requires capturing latent patterns in longitudinal omics data.
By Yue Zhao, Thierry Chekouo, Sandra Safo
arXiv:2607. 28655v1 Announce Type: cross Abstract: Small-area estimation (SAE) enables researchers and policymakers to identify spatial disparities in health outcomes, but survey-based SAE products carry an inherent lag.
By Aanya Gupta, Szandra P\'eter, Sara Von Hoene, Emma Von Hoene, Taylor Anderson
arXiv:2606. 00345v1 Announce Type: new Abstract: Wearable and mobile sensing technologies enable continuous monitoring of human behavior and health in real-world settings.
By Flavio Di Martino, Mattia G. Campana, Marcello Magno, Lorenza Pratali, Franca Delmastro
arXiv:2606. 09860v1 Announce Type: cross Abstract: Non-alcoholic fatty liver disease (NAFLD) affects roughly 25% of global adults, posing substantial hepatic and cardiovascular risks.
By Xinze Zhang
arXiv:2607. 14190v1 Announce Type: new Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive and heterogeneous neurodegenerative disease in which predicting clinically meaningful milestones, such as assistive device use, remains challenging.
By Zongliang Yue, Qi Li, Terry Heiman-Patterson, Frank Bearoff, Zhaohui Qin, Huanmei Wu
arXiv:2606. 16056v1 Announce Type: new Abstract: Dysglycemia, encompassing both prediabetes and diabetes, affects huge numbers of adults worldwide, yet many of them remain undiagnosed.
By Black Sun, Chenyi Zhang, Kaiyi Ji, Xi Lu
arXiv:2606. 12699v1 Announce Type: cross Abstract: Type 2 Diabetes (T2D) poses an increasing global health threat, demanding effective glycemic assessment to support personalized and improved diabetes care.
By Yifan Gao, Yanmin Gong, Yun Shi, Yuanxiong Guo
arXiv:2605. 22759v2 Announce Type: replace Abstract: While ubiquitous wearable sensors capture a wealth of behavioral and physiological information, effectively transforming these signals into personalized health insights is challenging.
By Girish Narayanswamy, Maxwell A. Xu, A. Ali Heydari, Samy Abdel-Ghaffar, Marius Guerard, Kara Vaillancourt, Zhihan Zhang, Jake Garrison, Levi Albuquerque, Dimitris Spathis, Hong Yu, Hamid Palangi, Xuhai "Orson" Xu, David G. T. Barrett, Joseph Breda, Jed McGiffin, Yubin Kim, Yuwei Zhang, Naghmeh Rezaei, Samuel Solomon, Karan Ahuja, Tim Althoff, Jake Sunshine, Ming-Zher Poh, Benjamin Yetton, Ari Winbush, Nicholas B. Allen, James M. Rehg, Isaac Galatzer-Levy, Yun Liu, John Hernandez, Anupam Pathak, Conor Heneghan, Yuzhe Yang, Ahmed A. Metwally, Pushmeet Kohli, Mark Malhotra, Shwetak Patel, Xin Liu, Daniel McDuff